Literature DB >> 823803

Recent studies in the epidemiology of tuberculosis, based on the risk of being infected with tubercle bacilli.

I Sutherland.   

Abstract

This review describes recent epidemiological studies, based upon the risk of infection with tubercle bacilli. In the Netherlands the risk of infection has been decreasing steeply and exponentially for many years, but in some developing countries there was little secular trend in the absence of intensive control measures. Variations in the risk of infection with age are being examined. A comprehensive statistical analysis has shown that the major risk of development of tuberculosis is following a recent primary infection; the risk is smaller following reinfection of a previously infected subject, and is very small indeed, in the absence of reinfection, if the primary infection took place more than 5 years previously.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 823803

Source DB:  PubMed          Journal:  Adv Tuberc Res        ISSN: 0065-3500


  48 in total

Review 1.  Mycobacterium tuberculosis in the extracellular compartment: an underestimated adversary.

Authors:  Jacques Grosset
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

Review 2.  [Genetics of susceptibility and resistance to tuberculosis].

Authors:  R D Horstmann
Journal:  Internist (Berl)       Date:  2003-11       Impact factor: 0.743

3.  The long-term health and economic benefits of DOTS implementation in Ecuador.

Authors:  Olivia Oxlade; Judyth Vaca; Elizabeth Romero; Kevin Schwartzman; Brian Graham; Lucero Hernandez; Terry Tannenbaum; Dick Menzies
Journal:  Can J Public Health       Date:  2006 Jan-Feb

Review 4.  The Mycobacterium tuberculosis MEP (2C-methyl-d-erythritol 4-phosphate) pathway as a new drug target.

Authors:  Hyungjin Eoh; Patrick J Brennan; Dean C Crick
Journal:  Tuberculosis (Edinb)       Date:  2008-09-14       Impact factor: 3.131

5.  Polymorphisms in TLR4 and TNFA and Risk of Mycobacterium tuberculosis Infection and Development of Active Disease in Contacts of Tuberculosis Cases in Brazil: A Prospective Cohort Study.

Authors:  Juan Manuel Cubillos-Angulo; María B Arriaga; Elisângela C Silva; Beatriz L A Müller; Daniela M P Ramalho; Kiyoshi F Fukutani; Pryscila F C Miranda; Adriana S R Moreira; Antonio Ruffino-Netto; Jose R Lapa E Silva; Timothy R Sterling; Afrânio L Kritski; Martha M Oliveira; Bruno B Andrade
Journal:  Clin Infect Dis       Date:  2019-08-30       Impact factor: 9.079

6.  Risk Factors for Tuberculosis and Effect of Preventive Therapy Among Close Contacts of Persons With Infectious Tuberculosis.

Authors:  Mary R Reichler; Awal Khan; Timothy R Sterling; Hui Zhao; Bin Chen; Yan Yuan; Joyce Moran; James McAuley; Bonita Mangura
Journal:  Clin Infect Dis       Date:  2020-04-10       Impact factor: 9.079

Review 7.  Mixed-strain mycobacterium tuberculosis infections and the implications for tuberculosis treatment and control.

Authors:  Ted Cohen; Paul D van Helden; Douglas Wilson; Caroline Colijn; Megan M McLaughlin; Ibrahim Abubakar; Robin M Warren
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

8.  Tuberculosis incidence among contacts of active pulmonary tuberculosis.

Authors:  M Cailleaux-Cezar; D de A Melo; G M Xavier; C L G de Salles; F C Q de Mello; A Ruffino-Netto; J E Golub; A Efron; R E Chaisson; M B Conde
Journal:  Int J Tuberc Lung Dis       Date:  2009-02       Impact factor: 2.373

9.  Can workplaces be predictors for recent onset latent tuberculosis in health care workers?

Authors:  Kittisak Sawanyawisuth; Naesinee Chaiear; Kanlayanee Sawanyawisuth; Panita Limpawattana; Janpen Bourpoern; Wipa Reechaipichitkul; Ken Takahashi
Journal:  J Occup Med Toxicol       Date:  2009-07-24       Impact factor: 2.646

10.  Saudi guidelines for testing and treatment of latent tuberculosis infection.

Authors:  Hamdan H Al Jahdali; Salim Baharoon; Abdullah A Abba; Ziad A Memish; Abdulrahman A Alrajhi; Ali AlBarrak; Qais A Haddad; Mohammad Al Hajjaj; Madhukar Pai; Dick Menzies
Journal:  Ann Saudi Med       Date:  2010 Jan-Feb       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.